Diverging trends of plasticizers (phthalates and non
Background European chemicals management aims to protect human health and the environment from legacy and emerging contaminants. The plasticizer market changed in response to the restriction of low molecular weight (LMW) phthalate plasticizers such as Di (2-ethylhexyl) phthalate (DEHP) due to their hazardous properties. We investigated patterns and trends of 19 regulated and emerging
Plasticizers - Chemical Economics Handbook (CEH) | S&P Global
Phthalates accounted for over 55% of world consumption of plasticizers in 2025, down from approximately 60–65% a few years ago; they are forecast to account for 50–55% of world consumption in the coming years. The decrease in market share has largely been due to the following:
FDA Limits the Use of Certain Phthalates in Food Packaging
This action also results in limiting the use of phthalates in food contact applications to nine phthalates – eight authorized for use as plasticizers and one authorized for use as a monomer.
Guideline on the use of phthalates as excipients in human
on the impact of phthalate exposure are limited and therefore the clinical relevance of such findin gs remains to be established. The most commonly used phthalates in medicinal products licensed in the EU are: dibutyl phthalate (DBP), diethyl phthalate (DEP), polyvinyl acetate phthalate (PVAP), cellulose
Colombia: Extension of definitive antidumping duty on imports
On January 16, 2014, the Colombian Ministry of Commerce, Industry and Tourism decided to initiate an anti-dumping investigation on imports of plasticizer DOP (diethylhexyl phthalate) from Mexico and South Korea (Resolution 005, 16.01.2014). The product subject to investigation is classified under the following HS code: 2917.3200.
